ED
Therapeutic Areas
HemostOD Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Universal Platelets | Thrombocytopenia (HLA-refractory) | Pre-clinical |
| CAR-PLT | Tissue-targeted cargo delivery (miRNA/siRNA/proteins) | Pre-clinical |
| Regenerative Medicine | Wound healing, anti-inflammatory, immunomodulation | Research |
| Platelet Lysate | Cell culture media supplement | Research |